Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Larch turpentine is a natural oleoresin obtained from the European larch (*Larix decidua*), manufactured by Herbrand PharmaChemicals as an active pharmaceutical ingredient (API) according to Pharmacopoeia Helvetica (Ph. Helv.) standards. As a complex mixture of resin acids (such as abietic acid) and essential oils (terpenes), it functions primarily as a rubefacient and counter-irritant, inducing local vasodilation and increased blood flow when applied topically. It also exhibits mild antiseptic properties. It is traditionally used in the formulation of ointments, plasters, and liniments for the treatment of minor aches, pains, boils (furuncles), and respiratory ailments through inhalation. In addition to human pharmaceutical use, it is widely utilized in veterinary medicine for hoof care and wound management.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on larch turpentine.